Influenza virus vaccine intranasal

Drug Profile

Influenza virus vaccine intranasal

Latest Information Update: 12 Jan 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hadassah Medical School
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Influenza virus infections

Most Recent Events

  • 12 Jan 2004 No development reported - Clinical-Phase-Unknown for Influenza virus infections in Israel (Intranasal)
  • 11 Jan 2000 A study in elderly volunteers has been added to the Viral Infections immunogenicity section
  • 12 Oct 1999 A study has been added to the adverse events section and the Viral Infections immunogenicity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top